Handelsbanken Fonder’s Avanos Medical AVNS Stock Holding History

Handelsbanken Fonder’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,216	Closed	-$210K	–	1567
2023 Q2	$210K	Hold	8,216	–	–	﹤0.01%	1480
2023 Q1	$244K	Hold	8,216	–	–	﹤0.01%	1381
2022 Q4	$222K	Buy	+8,216	New	+$201K	﹤0.01%	1390
2022 Q2	–	Sell	-9,716	Closed	-$325K	–	1619
2022 Q1	$325K	Hold	9,716	–	–	﹤0.01%	1475
2021 Q4	$337K	Sell	9,716 -4,600	-32%	-$149K	﹤0.01%	1571
2021 Q3	$447K	Hold	14,316	–	–	﹤0.01%	1425
2021 Q2	$521K	Buy	14,316 +6,200	+76%	+$256K	﹤0.01%	1352
2021 Q1	$355K	Hold	8,116	–	–	﹤0.01%	1375
2020 Q4	$372K	Hold	8,116	–	–	﹤0.01%	1313
2020 Q3	$270K	Hold	8,116	–	–	﹤0.01%	1288
2020 Q2	$239K	Buy	+8,116	New	+$235K	﹤0.01%	1314

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Handelsbanken Fonder's AVNS Position: Q3 2023 in Review

Handelsbanken Fonder sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 8,216 shares — an estimated $210K sold.

Handelsbanken Fonder first reported a position in AVNS in Q2 2020 and held it in 11 quarters. The position peaked at $521K in Q2 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

Handelsbanken Fonder reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
Handelsbanken Fonder sold 8,216 Avanos Medical shares in Q3 2023, an estimated $210K.
Handelsbanken Fonder first reported a position in Avanos Medical in Q2 2020 and held it in 11 quarters.
Handelsbanken Fonder's Avanos Medical position peaked at $521K in Q2 2021.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.